Pernix Therapeutics Holdings (PTX) Reports Q1 EPS of $0.04, Revenue Increased 14% Y/Y
Tweet Send to a Friend
Pernix Therapeutics Holdings (NYSE: PTX) reported Q1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
